Flexibility--the guiding principle for antibody manufacturing.
Ensuring adequate manufacturing capacity for recombinant and monoclonal antibodies is one of the greatest challenges facing the biotech industry. The following factors should be taken into account when designing product development and production strategies.
Carson
Keith L
KL
The Williamsburg BioProcessing Foundation, Foundation PO Box 1229, 1206 Laskin Road, Suite 201, Virginia Beach, Virginia 23451, USA. kcarson@wilbio.com
D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry*; D001702:Biopharmaceutics / Q000379:methods* / Q000639:trends; D001709:Biotechnology / Q000379:methods; D002626:Chemistry, Pharmaceutical / Q000379:methods; D004345:Drug Industry / Q000379:methods; D006801:Humans; D051379:Mice; D012109:Research Support as Topic; D013678:Technology, Pharmaceutical
D000911:Antibodies, Monoclonal